Vogt Sebastian, Portig Irene, Kusch Björn, Pankuweit Sabine, Sirat Abdul Sami, Troitzsch Dirk, Maisch Bernhard, Moosdorf Rainer
Department of Cardiovascular Surgery, Philipps-University Hospital, Marburg, Germany.
Ann Thorac Surg. 2004 Sep;78(3):883-9; discussion 889. doi: 10.1016/j.athoracsur.2004.03.082.
Recent findings indicate that molecular chaperones actively participate in myocardial cytoprotection. Moreover, ischemic tolerance can be induced in humans by brief ischemic events. Therefore, we investigated patients with severe angina attacks before coronary artery bypass grafting. We focused on appearance of anti-hsp70 antibodies as an immunologic response to heat shock protein induction by ischemia followed up by hemodynamic measurements perioperatively. We correlated these clinical findings with the presence of antibodies against hsp70 and the antioxidative capacity of patients' sera.
Thirty-five consecutive patients with coronary artery disease scheduled for coronary artery bypass grafting were included. Seventeen patients had severe angina, and 18 patients suffered from chronic stable angina preoperatively. In the patients' sera, antibodies against hsp70 were detected by enzyme-linked immunosorbent assay, and antioxidative capacity was detected using the chromogen assay. Cardiac output and pulmonary capillary wedge pressure were measured using a thermodilution catheter. We also evaluated C-reactive protein and creatine kinase MB isoenzyme, and performed a conventional leukocyte count.
The sera of the 17 patients with severe angina attacks before surgery contained antibodies against hsp70 and a low antioxidative capacity. The interval between a severe angina attack and anti-hsp70 antibody titer are inversely correlated. These patients had better cardiac output and lower pulmonary capillary wedge pressure values after surgery.
Severe angina before cardiac surgery coincided with an improved outcome as measured by hemodynamic variables as compared with chronic stable angina. This finding correlated significantly with a low antioxidative capacity and the presence of antibodies against hsp70. These pathophysiologic mechanisms might therefore play a role in myocardial protection.
最近的研究结果表明,分子伴侣积极参与心肌细胞保护。此外,短暂的缺血事件可在人类中诱导缺血耐受。因此,我们对冠状动脉旁路移植术前严重心绞痛发作的患者进行了研究。我们重点关注抗热休克蛋白70(hsp70)抗体的出现,这是对缺血诱导的热休克蛋白的免疫反应,并在围手术期进行血流动力学测量。我们将这些临床发现与抗hsp70抗体的存在以及患者血清的抗氧化能力相关联。
纳入35例计划进行冠状动脉旁路移植术的冠心病连续患者。17例患者术前有严重心绞痛,18例患者术前患有慢性稳定型心绞痛。采用酶联免疫吸附测定法检测患者血清中抗hsp70抗体,采用显色测定法检测抗氧化能力。使用热稀释导管测量心输出量和肺毛细血管楔压。我们还评估了C反应蛋白和肌酸激酶MB同工酶,并进行了常规白细胞计数。
17例术前有严重心绞痛发作的患者血清中含有抗hsp70抗体,且抗氧化能力较低。严重心绞痛发作与抗hsp70抗体滴度之间的间隔呈负相关。这些患者术后的心输出量更好,肺毛细血管楔压值更低。
与慢性稳定型心绞痛相比,心脏手术前的严重心绞痛与血流动力学变量测量的改善结果相符。这一发现与低抗氧化能力和抗hsp70抗体的存在显著相关。因此这些病理生理机制可能在心肌保护中起作用。